Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine
作者： Michel Deschuyteneer , Abdelatif Elouahabi , Dominique Plainchamp , Michel Plisnier , Dominique Soete
DOI: 10.4161/HV.6.5.11023
关键词:
摘要: … In conclusion, the BeVs-produced HpV-16 and HpV-18 L1 VLps display key structural and immunological features, which contribute to the efficacy of CervarixTM vaccination. …
sci-hub.se 参考文章(0)